ALB – Albemarle Corporation

Albemarle Corporation Monthly Stock Report

Publication Date: November 13, 2025

Company Overview

Albemarle Corporation (NYSE: ALB), headquartered in Charlotte, North Carolina, stands as a leading provider of energy storage solutions in the specialty chemicals industry. Established in 1887, the company operates through three primary segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment focuses on lithium compounds essential for lithium batteries, while the Specialties segment provides bromine and specialized lithium solutions across various sectors, including automotive, aerospace, and pharmaceuticals. The Ketjen segment addresses the demand for clean fuel technologies and catalytic solutions. As a notable player within the specialty chemicals industry, which falls under the basic materials sector, Albemarle remains committed to innovative energy solutions and sustainability practices.

52-Week Price Performance Analysis

Albemarle Corporation’s stock has shown a robust performance over the past year, marked by significant fluctuations. The stock has traded between a fifty-two week low of $49.43 and a high of $113.91, showcasing a broad range of price movement and indicative of market volatility.

As of the last trading session, the stock is priced at $110.32. An analysis of its 52-week price chart shows a clear overall bullish trend. The stock experienced a pronounced downtrend from November to May, during which the price declined sharply to around $55. However, from May onwards, the stock has reversed this trend, exhibiting systematic higher highs and higher lows–a hallmark of strong upward momentum.

Key technical indicators reveal significant support and resistance levels. The $100 threshold, previously a resistance point, has recently been breached, suggesting a likely breakout. The new resistance is observed around $110.32, coinciding with past price highs. Should the stock retrace, the $90 level may act as a reliable support area, providing a cushion against unfavorable price moves.

The moving average has been trending upwards since June, adding to the bullish sentiment. Recent price action indicates a notable gain of approximately 10.39%, highlighting the potential for continued upward momentum. However, traders should remain vigilant for possible pullbacks to the $100 resistance level, potentially turning it into support.

Financial Performance and Metrics

Albemarle’s financial outlook remains robust, with total revenue reported at approximately $4.95 billion. This strong revenue performance underscores the company’s operational capabilities and market presence.

Key financial metrics include:
– EBITDA: Approximately $696.87 million, reflecting healthy margins and effective management of core operations.
– Total Shares Outstanding: 117,697,540, with 10,084,460 shares currently short, indicating a significant short interest of approximately 12.92%. This metric may suggest a degree of bearish sentiment among investors regarding near-term performance.

From a valuation perspective, analysts have set a range of target prices, indicating:
– High Target Price: $200.00
– Mean Target Price: Approximately $100.66
– Median Target Price: $93.00
– Low Target Price: $58.00

While the potential high signifies notable growth prospects, the variability in estimates highlights differing analyst outlooks amidst uncertain market conditions.

Recent News and Developments

Albemarle Corporation has been in the news recently due to several significant developments. On October 27, 2025, the company declared a quarterly dividend of $0.405 per share, maintaining an annual rate of $1.62. This dividend is scheduled for payment on January 2, 2026, to shareholders recorded by December 12, 2025.

In terms of stock activity, on November 7, 2025, shares surged by 6.49%, reaching $110.32. This increase was largely attributed to strategic asset sales and enhanced operational efficiencies amidst a challenging lithium market. The trading volume achieved approximately $430 million, marking the stock as the 297th highest ranked in U.S. market activity.

However, not all sentiment surrounding Albemarle has been positive. On May 13, 2025, Berenberg lowered its price target on the stock from $92.00 to $74.00, maintaining a Hold rating. The reduction was prompted by persistent declines in lithium prices, trading around $9,500 per tonne, which might affect earnings and operational forecasts.

Market Sentiment and Analyst Recommendations

The analyst consensus on Albemarle Corporation is currently leaning towards a “hold” recommendation. As per the latest data, the overall recommendation mean hovers at 2.65 (on a scale where lower numbers indicate stronger buy signals). A total of 23 analysts provided insights into the stock, with limited short-term growth opportunities reflected in their evaluations.

The majority of analysts suggest a cautious approach, favoring the maintenance of current positions to leverage potential stock performance as conditions evolve. The diverse target prices, ranging from a low of $58.00 to a high estimate of $200.00, reflect varying perspectives within the investment community concerning the stock’s future trajectory.

While modeling expectations around the lithium market remains critical, the recent price movements and sustained revenue growth illustrate Albemarle’s commitment to navigating market fluctuations effectively.

Conclusion

Albemarle Corporation positions itself as a significant player in the specialty chemicals industry, with promising financial health and a robust operational framework. Although recent market activities and investor sentiment indicate a hold recommendation, stakeholders should remain vigilant of market developments, especially in the lithium sector, to make informed investment decisions. The potential for substantial growth exists, encapsulated in the high-end price target, but prudent monitoring of both indicators and analyst insights will be crucial in managing risk and capitalizing on opportunities moving forward.

Metric	Value
Market Cap	$12.8b
Total Debt	$3.8b
Total Cash	$1.9b
Shares Outstanding	117.7m
Float Shares	117.1m